AB
Ashwin Balakrishnan
Physician · NorthBay Health
Credentials: · ·
History
Research
Safety of targeting ROR1 in primates with chimeric antigen receptor-modified T cells
Cancer Immunology Research · 2015 · 148 citations
Adoptive therapy with chimeric antigen receptor-modified T cells of defined subset composition
Review · The Cancer Journal · 2014 · 91 citations
Multispecific Targeting with Synthetic Ankyrin Repeat Motif Chimeric Antigen Receptors
Clinical Cancer Research · 2019 · Co-first of 9 authors · 51 citations
6 papers
5 papers · 4 as a resident
5 papers
5 papers
4 papers · 1 as a fellow
4 papers
3 papers · 1 as a fellow
3 papers · 3 as a fellow
